Drug Repurposing : Dipeptidyl
Peptidase IV DPP4 Inhibitors as Potential Agents to treat SARSCoV2 2019nCov Infection DPP4 activity is increased in patients with type2 diabetes and the increased risk of type2 diabetic patients to SARSCoV2 infection which suggests that DPP4 class of drugs have the potential to be used as novel therapy Our molecular modeling studies suggest that
Embed this Presentation
Available Downloads
Download Notice
Download Presentation The PPT/PDF document "Drug Repurposing : Dipeptidyl" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.